EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Actinium-225 in Targeted Alpha Therapy

A K M Rezaur Rahman, Mahathe Hasan Babu, Mustofa Khalid Ovi, Md Mahiuddin Zilani, Israt Sultana Eithu, Amit Chakraborty

Journal of Medical Physics · 2024-04 · 49 (2) · 137-147

DOI: 10.4103/jmp.jmp_22_24 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medical Physics, online erschienen am 25.06.2024. Verfasst von A K M Rezaur Rahman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, University of Chittagong, Chittagong, Bangladesh. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The utilization of actinium-225 ( 225 Ac) radionuclides in targeted alpha therapy for cancer was initially outlined in 1993. Over the past two decades, substantial research has been conducted, encompassing the establishment of 225 Ac production methods, various preclinical investigations, and several clinical studies. Currently, there is a growing number of compounds labeled with 225 Ac that are being developed and tested in clinical trials. In response to the increasing demand for this nuclide, production facilities are either being built or have already been established. This article offers a concise summary of the present state of clinical advancements in compounds labeled with 225 Ac. It outlines various processes involved in the production and purification of 225 Ac to cater to the growing demand for this radionuclide. The article examines the merits and drawbacks of different procedures, delves into preclinical trials, and discusses ongoing clinical trials.

Schlagwörter

Stichwörter der Autor:innen

Actinium-225alpha emitternuclear medicineoncologytargeted alpha therapy

Autor:innen und Institutionen

  • Department of Physics, University of Chittagong, Chittagong, Bangladesh.

Zitieren

APA

Rahman, A. K. M. R., Babu, M. H., Ovi, M. K., Zilani, M. M., Eithu, I. S., & Chakraborty, A. (2024). Actinium-225 in Targeted Alpha Therapy. Journal of Medical Physics, 49(2), 137-147. https://doi.org/10.4103/jmp.jmp_22_24

Vancouver

Rahman AKMR, Babu MH, Ovi MK, Zilani MM, Eithu IS, Chakraborty A. Actinium-225 in Targeted Alpha Therapy. Journal of Medical Physics. 2024;49(2):137-147. doi:10.4103/jmp.jmp_22_24

BibTeX
@article{Rahman2024,
  author = {Rahman, A K M Rezaur and Babu, Mahathe Hasan and Ovi, Mustofa Khalid and Zilani, Md Mahiuddin and Eithu, Israt Sultana and Chakraborty, Amit},
  title = {Actinium-225 in Targeted Alpha Therapy},
  journal = {Journal of Medical Physics},
  year = {2024},
  volume = {49},
  number = {2},
  pages = {137--147},
  doi = {10.4103/jmp.jmp_22_24}
}
Kostenlos starten →